Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3879362

Cn1c(=O)n(C)c2c(N3CCNCC3)nc(Cl)nc21.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
HRH4 Q9H3N8 2/20 0.36
IRAK4 Q9NWZ3 3/20 0.35
LMNA P02545 1/20 0.35
CYP2C9 P11712 1/20 0.35
ATP6V1B2 P21281 1/20 0.35
TBXA2R P21731 1/20 0.35
EDNRA P25101 1/20 0.35
TARBP2 Q15633 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
NUDT5 Q9UKK9 1/20 0.34
HTR2C P28335 2/20 0.33
POLB P06746 1/20 0.32
SIRT5 Q9NXA8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13866872 0.89 DPP4 (0.46) DPP4L3MBTL1KMT2AALDH1A1NUDT5
Trifluoroacetic Acid SCHEMBL3872986 0.85 DPP4 (0.41) DPP4L3MBTL1HRH4IRAK4LMNA
Trifluoroacetic Acid SCHEMBL3879690 0.85 DPP4 (0.52) DPP4L3MBTL1
Trifluoroacetic Acid SCHEMBL3886671 0.85 DPP4 (0.54) DPP4LMNAKMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL3872990 0.85 DPP4 (0.41) DPP4L3MBTL1HRH4IRAK4LMNA
Trifluoroacetic Acid SCHEMBL3876004 0.84 DPP4 (0.43) DPP4L3MBTL1LMNACYP2C9ATP6V1B2
Trifluoroacetic Acid SCHEMBL3884716 0.84 DPP4 (0.56) DPP4L3MBTL1LMNAALDH1A1
Trifluoroacetic Acid SCHEMBL3878860 0.84 DPP4 (0.39) DPP4L3MBTL1HRH4IRAK4LMNA
Trifluoroacetic Acid SCHEMBL3877706 0.81 DPP4 (0.39) DPP4HRH4IRAK4LMNACYP2C9
Trifluoroacetic Acid SCHEMBL3875820 0.77 DPP4 (0.43) DPP4HRH4LMNACYP2C9ATP6V1B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524847-B2 Fused 1,3-dihydro-imidazole ring compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-04-28 US disclosed
US-20060111362-A1 1,3-Dihydroimidazole ring compound EISAI CO., LTD. (JP) 2006-05-25 US disclosed
EP-1568699-A1 1,3-DIHYDROIMIDAZOLE FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111362-A1 1,3-Dihydroimidazole ring compound NR2C2, NR0B2, DPP4 DPP4 3/4885L3MBTL1 1953/4885HRH4 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.